Article Text

PDF

Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.
  1. I Takanami,
  2. T Imamura,
  3. T Hashizume,
  4. K Kikuchi,
  5. Y Yamamoto,
  6. S Kodaira
  1. Department of Pathology, Teikyo University School of Medicine, Tokyo, Japan.

    Abstract

    AIMS--To evaluate the efficacy of transforming growth factor beta (TGF-beta) for the prognosis of pulmonary adenocarcinoma. METHODS--TGF-beta was detected immunohistochemically using the avidin-biotin-peroxidase complex technique in resected pulmonary adenocarcinomas from 88 patients. RESULTS--Of the 88 patients, 39 were TGF-beta negative and 45 TGF-beta positive. The five year survival rate was 56% for the TGF-beta negative and 16% for the TGF-beta positive group. CONCLUSIONS--TGF-beta can be used as a prognostic factor in pulmonary adenocarcinoma.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.